Paris is on Track to Become the European Capital of Cleantech – are Foreign Investors Ready?

Jules Besnainou
European cleantech has been thriving in the past five years. In this period, investment into start-ups has more than doubled to $5.2 billion deployed over 566 deals in 2018, representing 28% of global cleantech deals. For the first time in years, France was one of the top two EU destinations for investment, places typically held by the UK, Germany and Israel. As it benefits from a wave of innovation and capital, a friendly government and looming Brexit, France could claim... Read More »

Whisper it Quietly, but European Cleantech Is Capturing Discerning Global Attention

Richard Youngman
European cleantech is in rude health. But if you're looking at the global news flow and its inevitable attention on the biggest ticket items and the hottest (over-hyped?) segments of the global industrial portfolio, you might conclude not so much is happening in Europe. You’d be wrong. In its typically understated way, the European innovation ecosystem is quietly thriving, dealflow is strong, technological excellence is to the fore, available funds for investment are increasing and there has been a strong... Read More »

Precision agriculture takes centre stage as the drone industry ascends to new heights

Chrysostomos Meli
The global drone industry has been growing exponentially in recent years, far beyond its traditional military market, and has attracted hundreds of millions in venture capital funding in the process. In 2015 alone the sector attracted $373 million in venture capital investment, a 5 fold increase from $67 million back in 2014. DJI and 3D Robotics first popularized the technology by providing aerial film capturing drones for amateur film makers and hobbyists. These companies have established the technology as a... Read More »

This Deal Matters: Evogene files for IPO

Amanda Faulkner
 Evogene, an Israeli developer of biotechnologies geared toward developing improved plants for agriculture and biofuel industries through use of plant genomics, filed for an IPO on the NYSE on November 11. The company plans to raised $86 million and would have a market value of $412 million at the midpoint of its proposed range. Evogene has established collaborative relationships with Monsanto, DuPont, Syngenta, and Bayer CropScience, showing real traction with the top players in the industry. While the public markets... Read More »